Loading chat...
NJ A6008
Bill
Status
11/17/2025
Primary Sponsor
Dawn Fantasia
Click for details
AI Summary
-
Expands the types of epinephrine delivery devices allowed in New Jersey schools from only pre-filled auto-injectors to any FDA-approved epinephrine administration mechanism
-
Requires public and nonpublic schools to maintain a supply of FDA-approved epinephrine administration devices in secure but unlocked, easily accessible locations for emergency use during anaphylactic reactions
-
School nurses and trained designees may administer epinephrine using any FDA-approved device to students experiencing anaphylaxis, including students without a known history of severe allergic reactions
-
Parents must provide written authorization and physician orders, and must sign liability waivers acknowledging they will indemnify schools for any injury arising from epinephrine administration
-
Permission for epinephrine administration must be renewed annually for each school year
Legislative Description
Expands epinephrine administration mechanisms permitted in schools.
Health
Last Action
Introduced, Referred to Assembly Health Committee
11/17/2025